Certain Common Stock of Medley, Inc. are subject to a Lock-Up Agreement Ending on 10-MAR-2020. These Common Stock will be under lockup for 90 days starting from 11-DEC-2019 to 10-MAR-2020.

Details:
In connection with the offer and the sale of the underwriter through the purchase transaction, the Sellers and company shareholders, Kohei Takiguchi, Goichiro Toyoda, Ryo Kahara, Hidetoshi Takano, Yosuke Ishizaki, Yusuke Shima, Kyosuke Kato, Makoto Kitada, Yuta Tamaru, Ken Teramachi and Kazuhiro Sugino, and our shareholders, One Grove Capital Co., Ltd., Toshihiro Yokoo, Daisuke Tanaka, Yui Sonoda, Toru Hashimoto, Tadashi Tsujii Noboru Kotani, Takayuki Kanematsu, Hiroshi Saiki, Isayoshi Owari, Keiichi Kato and Masahide Kamachi, the Company's warrants holders, Kohei Takiguchi, Goichiro Toyoda, Ryo Kahara Yosuke Ishizaki, Sosuke Hirayama, Yusuke Shima, Kyosuke Kato, Makoto Kitada, Yuta Tamaru, Toshihiro Yokoo, Takeshi Teramachi, Maaaki Inaba, Ryusuke Inamoto, Daisuke Tanaka, Kiyoshi Tanaka, Yui Sonoda Tadashi Tsujii Yuki Miyauchi Takayuki Kanematsu Hiroshi Saiki, Masaaki Takeuchi, Hirokazu Sugino, Ayumi Hashimoto, Mitsue Ogawa, Kuniori Maeda Noriko Nakajima, Satoru Hiraki Fumiya Fujino Hiromune Shishido Hiroshi Shimoyamada Kentaro Fukuda Tomomi Tamura Manami Ono Masaya Hagiri Ryoko Suzuki Yoshihiko Yoshida Aoi Matsuya Yuka Shintani Yang Chuntao Yosuke Shirai Takuma Goto Makoto Tateno Shogo Maekawa Hiromi Ishizaka Hasumi Fukazawa Keisuke Koyama Yasunori Ooka Kensuke Fukuda Takanori Sasaki and Masanori Kusaka have agreed with the joint lead company that during the period from the date of signing the original underwriting contract to the 180th day (June 8, 2020) after the listing date (including the current day), they will not sell the Company's common stock without the prior written consent of the joint lead company.

The sellers and our shareholders Incubate No. 1 Fund L.P., Kyosuke Shirasaki, East Ventures Fund L.P., Nissei Capital No. 6 Fund L.P., Nippon Life Insurance Company, Globis No. 5 Fund L.P., SMBC Trust Bank Ltd. (Trust account outside specified investment trust contract number 12100440) (Note) 9,Tatsuo Mizuno, Ken Honda, Globis Fund V, L. P., Tamao Yanauchi, Global Brain No. 6 Fund L.P., Masahiro Sagehashi, Satoru Okamoto, East Ventures No.2 Fund L.P., Kazunari Maeda, Kaigen Pharma Co., Ltd., Masashige Den, Sho Okiyama, NISSAY CAPITAL CO.,LTD., Shusuke Fukuda, Masanori Kyo, and Kenta Fujita, as well as our shareholders, Shintaro Yamada, Yorihiro Hamuro, Nobuyoshi Yamagishi, Sequoia limited company and MSIVC2016V Fund L.P., Masashige Den, who holds our warrants and the Company has agreed with the joint lead company have agreed with the joint lead company that during the period from the date of the original underwriting contract to the 90th day (March 10, 2020) after the listing date (including the current day), they will not sell our common stock without the prior written consent of the joint lead company.